Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 82701-82750 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05533372
MAD Study of IA-14069
PHASE1Recruiting
75 participants
Started: Oct 10, 2022 · Completed: Feb 28, 2026
2 conditions1 sponsor1 location
NCT05515978
Pragmatic Trial of Metformin for Glucose Intolerance or Increased BMI in Prostate Cancer Patients
EARLY_PHASE1Recruiting
100 participants
Started: Oct 10, 2022 · Completed: Nov 6, 2036
1 condition1 sponsor4 locations
NCT05557045
A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815
PHASE1Recruiting
332 participants
Started: Oct 10, 2022 · Completed: Apr 1, 2028
3 conditions1 sponsor8 locations
NCT06863818
Overcoming Resistance to EGFR Neutralization by Combination of Monoclonal Antibodies and Novel Cancer Drugs
N/AActive, not recruiting
30 participants
Started: Oct 10, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05595460
Study of RYZ101 in Combination With SoC in Subjects With SSTR+ ES-SCLC
PHASE1Recruiting
49 participants
Started: Oct 10, 2022 · Completed: Mar 31, 2029
1 condition1 sponsor15 locations
NCT05575011
A Study to Learn About the Safety of BIIB115 Injections and How BIIB115 is Processed in the Bodies of Healthy Adult Male Volunteers and of Pediatric Participants With Spinal Muscular Atrophy Who Previously Took Onasemnogene Abeparvovec
PHASE1Active, not recruiting
62 participants
Started: Oct 10, 2022 · Completed: Nov 14, 2031
2 conditions1 sponsor17 locations
NCT05576896
Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab in the Treatment of Metastatic BRAF-mutated Colorectal Cancer Refractory
PHASE2Recruiting
43 participants
Started: Oct 10, 2022 · Completed: Jul 1, 2028
3 conditions2 sponsors1 location
NCT05580302
Cortical Silent Period in Laryngeal Dystonia
N/ARecruiting
20 participants
Started: Oct 10, 2022 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT06645626
Utilisation of Health Services and Quality of Life in Patients With Atypical Parkinsonian Syndromes
N/ARecruiting
198 participants
Started: Oct 10, 2022 · Completed: Jul 15, 2027
3 conditions1 sponsor1 location
NCT05562128
Effects of Forest Therapy on Physical and Psychological Parameters in the General Population - a Randomized Controlled Trial
NARecruiting
120 participants
Started: Oct 10, 2022 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT05463120
Minipuberty of Infancy and the Timing of Pubertal Development in Adolescence: a Follow-up of the Infant Feeding and Early Development (IFED) Cohort
N/AEnrolling by invitation
566 participants
Started: Oct 10, 2022 · Completed: Mar 1, 2026
1 condition1 sponsor2 locations
NCT05853692
Prevention of Oral Mucositis in Head and Neck Cancer.
NARecruiting
130 participants
Started: Oct 10, 2022 · Completed: Jun 10, 2026
1 condition1 sponsor1 location
NCT06009848
Cadonilimab Plus Nab-Paclitaxel for Recurrent or Metastatic Muscle Invasive Bladder Cancer
PHASE2Recruiting
20 participants
Started: Oct 10, 2022 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT05569070
Evaluation of Young United Parents
NAActive, not recruiting
1,400 participants
Started: Oct 10, 2022 · Completed: Sep 30, 2026
1 condition2 sponsors1 location
NCT04965038
Early Reperfusion Therapy With Intravenous Thrombolysis for Recovery of VISION in Acute Central Retinal Artery Occlusion
PHASE3Recruiting
422 participants
Started: Oct 10, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06005792
Multiple Ascending-Dose Study of XmAb®27564 in Patients With Psoriasis or Atopic Dermatitis
PHASE1Active, not recruiting
128 participants
Started: Oct 10, 2022 · Completed: May 31, 2026
2 conditions1 sponsor7 locations
NCT05020535
Biomarker and Edema Attenuation in IntraCerebral Hemorrhage (BEACH)
PHASE2Recruiting
120 participants
Started: Oct 10, 2022 · Completed: Oct 1, 2026
1 condition3 sponsors11 locations
NCT05550623
Pneumatic Tourniquet Versus no Tourniquet in Transfemoral Amputation
NAActive, not recruiting
124 participants
Started: Oct 10, 2022 · Completed: Sep 30, 2026
2 conditions2 sponsors1 location
NCT05416567
Embolization for Meningioma
NARecruiting
30 participants
Started: Oct 10, 2022 · Completed: Aug 31, 2037
1 condition1 sponsor1 location
NCT05999409
Normal Birth Management and Use of Simulation
NAActive, not recruiting
90 participants
Started: Oct 10, 2022 · Completed: Dec 10, 2023
1 condition2 sponsors1 location
NCT06333587
Minimally Invasive Treatments of the Thyroid
N/ARecruiting
270 participants
Started: Oct 10, 2022 · Completed: Dec 31, 2035
1 condition1 sponsor1 location
NCT05571280
Community-based, Controlled, Open-label, Cluster-randomized Trial for the Reduction of Chronic Malnutrition in Children Under Two Years of Age, With Three Intervention Arms Grouped by Clusters, in Two Provinces in Southern Angola, Huíla and Cunene.
NAActive, not recruiting
1,423 participants
Started: Oct 10, 2022 · Completed: Jul 31, 2026
1 condition3 sponsors2 locations
NCT05497427
Normative Database and Test-Retest Reliability for BrainCheck Assessments
N/ARecruiting
1,200 participants
Started: Oct 10, 2022 · Completed: Jan 31, 2025
4 conditions1 sponsor5 locations
NCT05273385
Efficacy of the Nanodropper Device on Intraocular Pressure in Patients With Glaucoma
NARecruiting
40 participants
Started: Oct 10, 2022 · Completed: Dec 10, 2024
3 conditions3 sponsors1 location
NCT05458700
POS-cUTI: Study on Complicated Urinary Tract Infections
N/ARecruiting
16,000 participants
Started: Oct 10, 2022 · Completed: Feb 28, 2026
1 condition3 sponsors1 location
NCT05508789
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
PHASE3Recruiting
1,500 participants
Started: Oct 10, 2022 · Completed: Jul 31, 2028
9 conditions1 sponsor141 locations
NCT06143085
Impact of Nonsurgical Periodontal Therapy on Oral Health Related Quality of Life
NARecruiting
72 participants
Started: Oct 10, 2022 · Completed: Jan 20, 2024
1 condition1 sponsor1 location
NCT07116759
Head Stabilization of Healthy Volunteers
N/AActive, not recruiting
21 participants
Started: Oct 9, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05416515
A Study of Fisetin to Treat Carpal Tunnel Syndrome
PHASE2Active, not recruiting
40 participants
Started: Oct 9, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05509790
A Study of LY3484356 in Chinese Participants With Advanced Breast Cancer
PHASE1Active, not recruiting
17 participants
Started: Oct 9, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor4 locations
NCT05427669
Adjuvant mFOLFOXIRI vs. mFOLFOX6 in MRD Positive Stage II-III Colorectal Cancer (AFFORD)
PHASE3Not yet recruiting
340 participants
Started: Oct 9, 2022 · Completed: Jul 1, 2027
1 condition1 sponsor0 locations
NCT05566600
Allogeneic iPSC-derived Cardiomyocyte Therapy in Patients With Worsening Ischemic Heart Failure
EARLY_PHASE1Recruiting
32 participants
Started: Oct 9, 2022 · Completed: Jul 31, 2025
2 conditions2 sponsors2 locations
NCT05592353
Effect of Post-operative Brace on Pain and Patient Outcomes Following Hip Arthroscopy for FAIS
NAActive, not recruiting
100 participants
Started: Oct 8, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06468293
Role of Caregiver in the Clinical Pathway of Patients With Breast and Prostate Cancer
NARecruiting
102 participants
Started: Oct 8, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT06506214
Characterizing Adherence to Treatment and Satisfaction With Care in Patients With Cutaneous Lupus
N/ARecruiting
233 participants
Started: Oct 8, 2022 · Completed: Oct 8, 2024
1 condition1 sponsor4 locations
NCT05313529
Evaluating the Effects of Liraglutide, Empagliflozin and Linagliptin on Mild Cognitive Impairment Remission in Patients With Type 2 Diabetes: a Multi-center, Randomized, Parallel Controlled Clinical Trial With an Extension Phase
NAActive, not recruiting
396 participants
Started: Oct 8, 2022 · Completed: Dec 31, 2025
2 conditions5 sponsors5 locations
NCT05577910
Vectored Thermal Pulsation, Intense Pulsed Light, and Eyelid Warm Compress Therapies for MGD
NAActive, not recruiting
360 participants
Started: Oct 8, 2022 · Completed: Jun 30, 2025
1 condition1 sponsor4 locations
NCT05344339
Billroth-II Modified Versus Roux-en-Y After Distal Gastrectomy for Gastric Cancer
NARecruiting
320 participants
Started: Oct 8, 2022 · Completed: Dec 31, 2028
2 conditions1 sponsor1 location
NCT05557318
Using Micro Electro Mechanical Systems to Detect the Air of Vaginal Discharge
NARecruiting
120 participants
Started: Oct 8, 2022 · Completed: Oct 31, 2025
2 conditions2 sponsors2 locations
NCT05851105
the Safety and Efficacy Evaluation of HGI-002 Injection in Patients With Transfusion-Dependent α-Thalassemia
EARLY_PHASE1Recruiting
3 participants
Started: Oct 8, 2022 · Completed: Dec 30, 2026
1 condition1 sponsor1 location
NCT05505812
Study on the Safety and Efficacy of Autogenous Tumor Infiltrates Lymphocytes for the Treatment of Advanced Breast Cancer
EARLY_PHASE1Not yet recruiting
10 participants
Started: Oct 8, 2022 · Completed: Mar 31, 2027
1 condition2 sponsors1 location
NCT05788822
MVA to Improve the Pregnancy Outcome in Aged Infertility Women With Assisted Reproductive Technology
NARecruiting
148 participants
Started: Oct 8, 2022 · Completed: Dec 31, 2025
4 conditions1 sponsor1 location
NCT05539768
Study on the Safety and Efficacy of Autogenous Tumor Infiltrates Lymphocytes for the Treatment of Advanced Solid Tumor
EARLY_PHASE1Not yet recruiting
8 participants
Started: Oct 8, 2022 · Completed: Mar 31, 2027
1 condition2 sponsors0 locations
NCT05282732
Retrospective Analysis of Performance and Treatment Data Collected for Genius SleddFlux Filter, Ultraflux AV 600 S Filter & Genius 90 Concentrates in Haemodialysis Patients
N/ARecruiting
100 participants
Started: Oct 7, 2022 · Completed: Dec 31, 2025
3 conditions2 sponsors2 locations
NCT05682482
LT4/LT3 Combination Therapy Versus LT4 Monotherapy in Patients with Autoimmune Hypothyroidism.
PHASE3Recruiting
600 participants
Started: Oct 7, 2022 · Completed: Jan 31, 2028
1 condition3 sponsors19 locations
NCT05569304
Endoscopic Sleeve Gastroplasty Versus GLP-1 Analogue for Class 1 and 2 Obesity Study
NANot yet recruiting
66 participants
Started: Oct 7, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05598996
The YourMove Study: Optimizing Individualized and Adaptive mHealth Interventions Via Control Systems Engineering Methods
NAActive, not recruiting
386 participants
Started: Oct 7, 2022 · Completed: Aug 9, 2025
2 conditions5 sponsors1 location
NCT05590988
Sensorimotor Arm Rehabilitation After Stroke
NARecruiting
36 participants
Started: Oct 7, 2022 · Completed: Mar 15, 2026
2 conditions2 sponsors1 location
NCT05487989
VIsual Pathways Model in Neuro-inflammatory Disorders
N/ARecruiting
100 participants
Started: Oct 7, 2022 · Completed: Apr 7, 2028
1 condition1 sponsor1 location
NCT05416164
DESCARTES: De-ESCAlation of RadioTherapy in Patients With Pathologic Complete rESponse to Neoadjuvant Systemic Therapy
NARecruiting
595 participants
Started: Oct 7, 2022 · Completed: May 31, 2037
1 condition3 sponsors1 location